loading...

The University of California, San Diego Shortness of Breath Questionnaire (SOBQ)

Archibald CJ; Guidotti TL; Eakin EG; Resnikoff PM; Prewitt LM; Ries AL; Kaplan RM

Distributed by Mapi Research Trust

ProQolid

Distributed by Mapi Research Trust

Basic description

Developed in 1987

Authors

Archibald CJ; Guidotti TL; Eakin EG; Resnikoff PM; Prewitt LM; Ries AL; Kaplan RM

Copyright
© 1995 The Regents of the University of California, rights reserved.
Objective
To assess dyspnea associated with activities of daily living (ADLs)
Therapeutic area
  • Respiratory Tract Diseases
  • Pathological Conditions, Signs and Symptoms
  • Digestive System Diseases
  • Congenital, Hereditary, and Neonatal Diseases and Abnormalities
  • Rare disease (Orphanet definition)
Therapeutic indication
  • Dyspnea
  • Pulmonary Disease, Chronic Obstructive
  • Cystic Fibrosis For more information on this rare disease, please consult the following link: Orphanet page
Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English for the USA
Bibliographic reference(s) of the original questionnaire

Archibald CJ, Guidotti TL. Degree of objectively measured impairment and perceived shortness of breath with activities of daily living in patients with chronic obstructive pulmonary disease. Can J Rehab. 1987;1:45-54.

Eakin EG, Sassi-Dambron DE, Ries AL, Kaplan RM. Reliability and validity of dyspnea measures in patients with obstructive lung disease. Int J Behav Med. 1995;2(2):118-34 (Full Text Article)

Eakin EG, Resnikoff PM, Prewitt LM, et al. Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. University of California, San Diego. Chest. 1998 Mar;113(3):619-24 (Full Text Article)

Kupferberg DH, Kaplan RM, Slymen DJ, Ries AL. Minimal clinically important difference for the UCSD Shortness of Breath Questionnaire. J Cardiopulm Rehabil. 2005 Nov-Dec;25(6):370-7 (Full Text Article)

Access this questionnaire

Licensing

Academic Users

It is not necessary to contact the UCSD to use the SOBQ for academic clinical research. Please follow the steps below to get translations from Mapi Research Trust.

For other types of use, please consult the UCSD.

Commercial Users

The use of the questionnaire is licensed by the UCSD.

A license agreement must be completed beforehand and a user fee is required.

Please contact:

Skip J. Cynar, PhD
Licensing Officer
UCSD - Off Innov. & Commer. (3rd Floor)
10300 N. Torrey Pines Road
La Jolla, CA 92037
Email: scynar@ucsd.edu

Then proceed with the steps below to get translations from Mapi Research Trust.

Distribution of Translations

Existing translations can be obtained from Mapi Research Trust. 

Submit your request (see tutorial). Our PROVIDE team will get back to you with the needed information and license agreement in a timely manner.


Contact and conditions of use

Authors

Archibald CJ; Guidotti TL; Eakin EG; Resnikoff PM; Prewitt LM; Ries AL; Kaplan RM

Andrew L. Ries MD, MPH, FCCP
UCSD School of Medicine,
9500 Gilman Drive, La Jolla,
CA 923093-0602
USA
Phone: +1 619-543-7350
E-mail: aries@ucsd.edu

Andrew L. Ries Publications (PubMed)

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Licensing

Academic Users

It is not necessary to contact the UCSD to use the SOBQ for academic clinical research. Please follow the steps below to get translations from Mapi Research Trust.

For other types of use, please consult the UCSD.

Commercial Users

The use of the questionnaire is licensed by the UCSD.

A license agreement must be completed beforehand and a user fee is required.

Please contact:

Skip J. Cynar, PhD
Licensing Officer
UCSD - Off Innov. & Commer. (3rd Floor)
10300 N. Torrey Pines Road
La Jolla, CA 92037
Email: scynar@ucsd.edu

Then proceed with the steps below to get translations from Mapi Research Trust.

Distribution of Translations

Existing translations can be obtained from Mapi Research Trust. 

Submit your request (see tutorial). Our PROVIDE team will get back to you with the needed information and license agreement in a timely manner.

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

Languages

Original language(s)

  • English for the USA

Translations

The listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.

SOBQ

Afrikaans for South Africa*
Arabic for Egypt*
Arabic for Israel*
Arabic for Saudi Arabia*
Arabic for the United Arab Emirates*
Bengali for India*
Czech for Czech Republic*
Danish for Denmark*
Dutch for Belgium (Flemish)*
Dutch for the Netherlands*
English for Australia*
English for Canada*
English for India*
English for New Zealand*
English for the UK*
Finnish for Finland*
French for Belgium*
French for Canada*
French for France*
German for Austria*
German for Germany*
Greek for Greece*
Gujarati for India*
Hebrew for Israel*
Hindi for India*
Hungarian for Hungary*
Italian for Italy*
Japanese for Japan*
Kannada for India*
Korean for South Korea*
Malayalam for India*
Mandarin for China*
Mandarin for Taiwan*
Marathi for India*
Polish for Poland*
Portuguese for Brazil*
Portuguese for Portugal*
Punjabi for India*
Russian for Israel*
Russian for Russia*
Spanish for Argentina*
Spanish for Chile*
Spanish for Mexico*
Spanish for Peru*
Spanish for Spain*
Spanish for the USA*
Swedish for Finland*
Swedish for Sweden*
Tamil for India*
Telugu for India*
Turkish for Turkey*
Urdu for India*
Xhosa for South Africa*
* Performed by Mapi

The author has selected Mapi/ICON Language Services as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.

For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).

Conditions to translate

Recommended vendor for translation work: Mapi/ICON Language Services

Academic Translation

If you wish to translate the questionnaire:

  1. Log in or Register for free
  2. Submit your request for translation online (Tutorials are available on our FAQs)
  3. Our PROVIDE team will send you a translation agreement along with Linguistic Validation Guidelines.

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us